China Monoclonal Antibodies Market to Witness Growth Acceleration by 2028

 

China monoclonal antibodies market is estimated to grow at a CAGR of nearly 9.2% during the forecast period. An increasing monoclonal antibody COVID-19 trials are offering scope for market growth. For instance, in June 2020, Chinese scientists introduced a phase I trial for the first neutralizing COVID-19 antibody treatment globally. This therapy has shown a promise in stopping the growth of novel coronavirus in animal testing, however, its effectiveness in humans’ rests to be seen. CB6 antibody functions by intervening with the attaching process between the Angiotensin-converting enzyme 2 (ACE2) receptor and the novel coronavirus, thereby blocks the virus from infecting cells. 

To Request a Sample of our Report on China Monoclonal Antibodies Market: https://www.omrglobal.com/request-sample/china-monoclonal-antibodies-market

By February 2020, two antibodies had discovered by researchers, CB6 and CA1, that have the potential viral neutralizing capability in vitro. Further, in July 2020, Junshi Biosciences declared the Phase I trial of SARS-CoV-2 neutralizing monoclonal antibody injection (JS016). This therapy is developed along with the Institute of Microbiology, Chinese Academy of Sciences (IMCAS). It is the first COVID-19 neutralizing antibody that is entering clinical trials in the country. During the second quarter of 2020, JS016 also entered clinical trials in the US.

Scope of the China Monoclonal Antibodies Market

Market Coverage

·        The market number available for – 2022-2028

·        Base year- 2021

·        Forecast period- 2022-2028

·        Competitive Landscape- AstraZeneca plc, Pfizer Inc., Innovent Biologics, Inc., Shanghai Fosun Pharmaceutical (Group) Co., Ltd., and Amgen Inc

Recent Strategic Initiatives in the China Monoclonal Antibodies Market

·        In December 2019, AstraZeneca declared that NMPA has granted marketing authorization for Imfinzi (durvalumab) to treat patients with unresectable, Stage III non-small cell lung cancer (NSCLC) whose disease has not progressed following concurrent platinum-based chemotherapy and radiation therapy (CRT). This approval represents the company’s long-standing commitment to improve the health outcomes of lung cancer patients in China. 

·        In October 2019, Amgen declared a partnership with BeiGene that will further widen Amgen's strategies to enhance the presence of its oncology products in China. Under the agreement, BeiGene will commercialize BLINCYTO (blinatumomab), XGEVA (denosumab), and KYPROLIS (carfilzomib) in China. Additionally, this acquisition will also support Amgen for the commercialization of its non-oncology product portfolio in China. 

A full Report of China Monoclonal Antibodies Market is Available at: https://www.omrglobal.com/industry-reports/china-monoclonal-antibodies-market

China Cancer Monoclonal Antibodies Market-Segmentation

By Source

·        Murine

·        Chimeric

·        Human

·        Humanized

By Application

·        Cancer

·        Infectious Diseases

·        Auto-Immune Diseases

·        Inflammatory Diseases

·        Others

Company Profiles

·        Amgen Inc.

·        Anhui Anke Biotechnology (Group) Co., Ltd.

·        AstraZeneca plc

·        CStone Pharmaceuticals

·        GenorBioPharma Co., Ltd.

·        Harbour BioMed (HBM)

·        Innovent Biologics, Inc.

·        Merck & Co., Inc.

·        Pfizer Inc.

·        Shanghai Fosun Pharmaceutical (Group) Co., Ltd.

·        Viva Biotech (Shanghai) Ltd.

·        Zhejiang Hisun Pharmaceutical Co., Ltd.

 Reasons to buy from us –

1.  We cover more than 15 major industries, further segmented into more than 90 sectors.

2.  More than 120 countries are for analysis.

3.  Over 100+ paid data sources mined for investigation.

4.  Our expert research analysts answer all your questions before and after purchasing your report.

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/china-monoclonal-antibodies-market

About Orion Market Research 

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

Media Contact:

Company Name: Orion Market Research

Contact Person: Mr. Anurag Tiwari

Email: info@omrglobal.com

Contact no:  +91 7803040404

Comments

Post a Comment

Popular posts from this blog

European Data Backup and Recovery Market Size, Share, Analysis, Industry Report and Forecast 2019-2025

  European Data Backup and Recovery Market are expected to reach $5.7 billion in 2027, growing at a CAGR of 9.5% during the forecast period (2021-2027). Factors responsible for the growth of the market in Europe are well-developed telecommunication infrastructure, high internet penetration, high adoption of cloud-based devices among people and organization. Regulations regarding the data localization such as GDPR by the European Union and countries own data localization and protection act are providing growth to the market. Major economies which are expected to hold a considerable market are UK, Germany, France, Italy, and Spain. These economies are part of the European Union, which covers most of the continent. The aim of the European Union was to increase economic cooperation and encourage free trade among countries. To Request a Sample of our Report on European Data Backup and Recovery Market :   https://www.omrglobal.com/request-sample/european-data-backup-recovery-...
Read more

Insect Repellent Market Is Likely to Experience a Tremendous Growth by 2031

This informative Insect Repellent Market report provides new method and covers foremost regions such as Latin America, Middle East, North America, Europe, Africa and Asia Pacific. Making most out of the consumer insights and market opportunities, market players can boost up the revenue rate of their business. It also permits key organizations to make communication with customers and know their demands for making right investment in the product development. By increasing the product portfolio by referring the important market data provided in this Insect Repellent Market research report, key players can grow and expand their business forward. Continuously developing customer demands are also described in this global report to help new entrants make required changes in the final product launch and then bring into the market. It becomes easy for key players to prioritize the demands and requirements of target audience and have complete understanding of end-user experience with the help o...
Read more

Asia-Pacific Urban Air Mobility Market Growth, Size, Share, Industry Report and Forecast 2019-2025

The Asia-Pacific urban air mobility market is estimated to grow at a CAGR of 12.6% during the forecast period. The Asia-Pacific urban air mobility market is segmented on the basis of component and operation. Based on the component, the market is further segmented into infrastructure and platform. The infrastructure segment is further segmented into charging stations, traffic management, and others whereas, the platform segment is further classified into air taxi, personal air vehicle, air ambulance, and others. The platform segment dominated the global urban air mobility market. To Request a Sample of our Report on Asia-Pacific Urban Air Mobility Market :   https://www.omrglobal.com/request-sample/asia-pacific-urban-air-mobility-market Asia-Pacific is home to several emerging economies and is seen as the potential market for the UAM owing to growing urbanization coupled with increasing traffic congestion and increasing high-income groups in the region. The growth of the As...
Read more